Patience C. Ennis is a registered nurse, author, Results Coach, glucagon-like peptide-1 (GLP-1) user, and the founder of Body Compass, an education and navigation platform for people living with, considering, or moving beyond GLP-1 treatment. A graduate of King's College London, she draws on more than three decades of clinical experience across emergency, community, palliative, and aged care, bringing together clinical knowledge, lived experience, and patient education to address the questions that often sit beyond the prescription.
Through Body Compass, she develops evidence-informed resources, books, practical tools, news updates, and non-clinical coaching support designed to help people understand changing appetite, side effects, strength, food noise, treatment adaptation, maintenance, and stopping. Her work is grounded in clarity, dignity, and honest interpretation of evidence, without hype, shame, or false certainty. Her aim is not to tell people what to decide, but to help them understand the terrain, ask better questions, and navigate metabolic health with greater confidence in everyday life and care.
She is the author of When GLP-1 Feels Different: Plateau, Food Noise, Adaptation and the Fear of "Resistance" (2026), available on Amazon and through Body Compass. Her other titles include Living Well on GLP-1 Medication: A Practical Guide to Everyday Life Beyond the Prescription, The Body Compass 30-Day Navigation Diary: A Reflective Daily Companion for GLP-1 Treatment, and The 30-Day GLP-1 Navigation Companion: Observation, Reflection, Preparation, Navigation.
She shares updates on LinkedIn, Facebook, the Body Compass Facebook page, Instagram, X, TikTok, and YouTube.
For nine months, I did not stand on a scale. I did not look at myself in a full-length mirror. I told myself I was busy. The truth was that I was frightened of what I might see.
I had reached my target weight, and my BMI had fallen below the range my prescriber and I intended. We discussed reducing my dose. Clinically, it was reasonable. Psychologically, it felt like a …
When the food noise stops, the identity crisis begins
She had five close friends. She told one.
Not because she doubted the prescription. Her GP had raised tirzepatide after her bloodwork showed worsening insulin resistance, and the decision followed a real clinical conversation. She told one friend because she did not know what the truth might do to the other four relationships.
Would her weight loss still count? Would lunch become surveillance? Would every smaller portion be treated as evidence? Would …
GLP-1 weight loss stigma changes what patients disclose
I have been a registered nurse for more than thirty years. I am also a bariatric surgery patient and a glucagon-like peptide-1 (GLP-1) user.
I thought that combination would put me in a good position when I started treatment. I understood medications and adverse effects. I knew hydration, nutrition, and maintaining strength mattered, and that success could not be measured only by the scale. Even so, I found myself working things …
What to expect on weight-loss medication, beyond the scale
Get free updates delivered free to your inbox.
